Invention Grant
- Patent Title: Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists
-
Application No.: US17224161Application Date: 2021-04-07
-
Publication No.: US11697646B2Publication Date: 2023-07-11
- Inventor: Yan Shi , Peter Tai Wah Cheng , Ying Wang , Jun Shi , Shiwei Tao , Jun Li , Lawrence J. Kennedy , Robert F. Kaltenbach, III , Hao Zhang , James R. Corte
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D403/04 ; C07D249/06 ; A61P35/00 ; A61P1/16 ; A61P19/10 ; A61P13/12 ; A61P11/00 ; C07C249/06 ; C07C403/04
Abstract:
The present invention provides compounds of Formula (I):
or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors.
Public/Granted literature
- US20220324829A1 TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Public/Granted day:2022-10-13
Information query
